Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2022

22-07-2022 | Adrenocortical Carcinoma | Editorial

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021

Authors: Alfredo Berruti, Massimo Terzolo, Sebastiano Filetti

Published in: Endocrine | Issue 3/2022

Login to get access

Excerpt

Adrenocortical carcinoma (ACC) is an extremely rare malignancy, whose molecular pathogenesis is incompletely understood [1] and treatment strategies are limited [2]. An international Symposium, held in Ann Arbor in 2003 [3], stimulated international collaborations. Since then, the ACC international research community has grown over time and meets every 2 years in a Symposium where advances in the pathogenesis and therapy of this rare disease are discussed. The 8th edition of this Symposium was organized by Alfredo Berruti and Massimo Terzolo and was held in Brescia from September 30 to October 2, in a Webinar mode due to SARS COV-2 pandemic. …
Literature
1.
S. Grisanti, D. Cosentini, S. Sigala, A. Berruti, Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021. Curr. Opin. Oncol. 34(1), 19–28 (2022)CrossRef
2.
S. Grisanti, D. Cosentini, M. Laganà et al. Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures. Curr. Opin. Endocr. Metab. Res. 8, 80–87 (2019)CrossRef
3.
D.E. Schteingart, G.M. Doherty, P.G. Gauger, T.J. Giordano, G.D. Hammer, M. Korobkin, F.P. Worden, Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr. Relat. Cancer 12(3), 667–680 (2005)CrossRef
4.
5.
M. Tamburello, B. Altieri, I. Sbiera, S. Sigala, A. Berruti, M. Fassnacht, S. Sbiera, FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma. Endocrine. (2022). https://​doi.​org/​10.​1007/​s12020-022-03074-z. Epub ahead of print
6.
7.
M. Faron, L. Lamartina, S. Hescot, S. Moog, F. Deschamps, C. Roux, R. Libè, J. Hadoux, E. Baudin, New endpoints in Adreno Cortical Carcinoma studies: a mini review. Endocrine (2022)
8.
R. Ambrosini, M.C. Balli, M. Laganà, M. Bertuletti, L. Bottoni, F. Vaccher, D. Cosentini, M. Di Terlizzi, S. Sigala, S. Grisanti, G.A.M. Tiberio, A. Berruti, L. Grazioli, Adrenocortical carcinoma and CT assessment of therapy response: the value of combining multiple criteria. Cancers 12(6), 1395 (2020)CrossRef
9.
R.V. Steenaard, L.A. Michon, H.R. Haak, Health-related quality of life in adrenocortical carcinoma. Cancers 11(10), 1500 (2019)CrossRef
10.
A. Turla, M. Laganà, S. Grisanti, A. Abate, V.D. Ferrari, V. Cremaschi, S. Sigala, F. Consoli, D., Cosentini, A. Berruti, Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen. Endocrine. (2022). https://​doi.​org/​10.​1007/​s12020-022-03075-y. Online ahead of print
11.
M. Laganà, S. Grisanti, D. Cosentini, V.D. Ferrari, B. Lazzari, R. Ambrosini, C. Sardini, A.D. Volta, C. Palumbo, P.L. Poliani, M. Terzolo, S. Sigala, G.A.M. Tiberio, A. Berruti, Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the brescia experience. Cancers 12(4), 941 (2020)CrossRef
Metadata
Title
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021
Authors
Alfredo Berruti
Massimo Terzolo
Sebastiano Filetti
Publication date
22-07-2022
Publisher
Springer US
Published in
Endocrine / Issue 3/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03147-z

Other articles of this Issue 3/2022

Endocrine 3/2022 Go to the issue

Original Article

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1

Original Article

Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life

Original Article

Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes

Original Article

Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study

Original Article

The role of surgery in small differentiated thyroid cancer

Original Article

Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits